Bitget App
Mag-trade nang mas matalino
Buy cryptoMarketsTradeFuturesEarnSquareMore
Price
Data
About
GILD stock price forecast
News
Competitors
Tokenization
Crypto
FAQ
Gilead Sciences, Inc. stock logo

Gilead Sciences, Inc.

GILD·NASDAQ

Huling na-update noong 2026-02-11 11:46 EST. Ang impormasyon sa presyo ng stock ay nagmumula sa TradingView at sumasalamin sa real-time market prices.

Insights
Calculator
News

GILD stock price change

Sa huling araw ng trading, GILD sarado ang stock sa 149.96 USD, na may pagbabago sa presyo ng -1.13% para sa araw.
Trade stock futures

Tungkol kay Bitget

Ang unang Universal Exchange (UEX) sa mundo, na nagbibigay-daan sa mga gumagamit na mag-trade hindi lamang ng mga cryptocurrency, kundi pati na rin ng mga stock, ETF, forex, gold, at mga real-world asset (RWA).
Learn more

GILD key data

Previous close149.96 USD
Market cap186.05B USD
Volume1.28M
P/E ratio23.23
Dividend yield (TTM)2.08%
Dividend amount0.79 USD
Last ex-dividend dateDec 15, 2025
Last payment dateDec 30, 2025
EPS diluted (TTM)6.46 USD
Net income (FY)480.00M USD
Revenue (FY)28.73B USD
Next report dateFeb 10, 2026
EPS estimate1.810 USD
Revenue estimate-
Shares float1.24B
Beta (1Y)0.17
Tokenized stocks

Nakarinig ka na ba ng tungkol sa mga tokenized stock?

Isang bagong paraan ng trade stocks — anumang oras, kahit saan, 24/7.

Learn more

Gilead Sciences, Inc. overview

Ang Gilead Sciences, Inc. ay isang biopharmaceutical na kumpanya na nakatuon sa pananaliksik, pag-develop, at komersyalisasyon ng mga gamot para sa mga larangan na may hindi pa natutugunang pangangailangang medikal. Pangunahing pokus ng kumpanya ang human immunodeficiency virus, acquired immunodeficiency syndrome, mga sakit sa atay, hematology, oncology, at mga sakit na may kaugnayan sa pamamaga at respiratory system. Nag-aalok ito ng mga antiviral na produkto sa ilalim ng mga brand na Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, at Vosevi. Itinatag ang kumpanya ni Michael L. Riordan noong Hunyo 22, 1987 at ang punong-tanggapan ay nasa Foster City, California.
Sector
Teknolohiyang pangkalusugan
Industry
Bioteknolohiya
CEO
Daniel P. ODay
Headquarters
Foster City
Website
gilead.com
Founded
1987
Employees (FY)
17.6K
Change (1Y)
−400 −2.22%
Revenue / Employee (1Y)
1.63M USD
Net income / Employee (1Y)
27.27K USD

GILD Pulse

Daily updates on GILD stock prices, fund flows, and market news, generated by AI and reviewed by our team of analysts. Always DYOR.

• Pagbabago sa presyo ng GILD Stock sa loob ng 24h: -0.54%. Mula 152.50 USD pababa sa 151.68 USD. (Tandaan: Ang mga presyo ay sumasalamin sa pinakabagong trading session bago ang Q4 2025 earnings release noong Pebrero 10).
• Mula sa teknikal na pananaw, nagpapakita ang merkado ng "malakas na bullish trend na may babala sa overbought": nananatiling mataas ang presyo sa ibabaw ng 50-day at 200-day SMAs, na nagpapahiwatig ng matibay na long-term momentum; gayunpaman, ang RSI ay malapit sa 82, na nagbababala ng posibleng short-term pullback o consolidation dahil ang stock ay teknikal na overbought.
• Iniulat ng Gilead Sciences ang Q4 2025 revenue na $7.9 bilyon, tumaas ng 5% taon-taon, na pinangunahan ng HIV at Liver Disease sales, kabilang ang matagumpay na paglulunsad ng dalawang beses sa isang taon na HIV prevention drug na Yeztugo.
• Inaprubahan ng FDA ang label update para sa Yescarta ng Kite (isang kumpanya ng Gilead), tinanggal ang mga limitasyon sa paggamit para sa relapsed/refractory primary central nervous system lymphoma, pinalawak ang saklaw ng paggamot.
• Ang positibong Phase 3 data na inilathala sa New England Journal of Medicine ay sumusuporta sa Trodelvy plus Keytruda bilang potensyal na bagong first-line standard of care para sa metastatic triple-negative breast cancer.
• Iniulat ng Amgen ang 8.6% revenue growth sa Q4, na nagpapahiwatig ng matatag na kapaligiran para sa large-cap therapeutics sa kabila ng mas malawak na volatility sa biotech sa buong 2025.
• Inilunsad ng White House ang "TrumpRx," isang online service para sa discounted drug sales, na nagpasimula ng malawakang diskusyon sa industriya tungkol sa pangmatagalang epekto sa presyo ng gamot at pagbabago sa federal healthcare policy.
See more
about 1D ago
• GILD Stock Price 24h change: +2.10%. Mula 149.37 USD hanggang 152.50 USD. Ang pagtaas ng presyo ay dulot ng positibong inaasahan ng merkado bago ang Q4 2025 earnings report at kamakailang paglawak ng FDA label para sa oncology portfolio nito.
• Sa teknikal na pananaw, ang stock ay nasa "Strong Buy" phase na may malakas na bullish momentum: Ang GILD ay nagte-trade sa itaas ng 50-day ($127.52) at 200-day ($116.77) moving averages. Gayunpaman, ang 14-day RSI ay nasa 74.16, na nagpapahiwatig na ang stock ay pumapasok na sa overbought territory at maaaring makaranas ng panandaliang konsolidasyon.
• Inaprubahan ng FDA ang update sa prescribing information ng Yescarta, inalis ang dating limitasyon sa paggamit para sa primary central nervous system lymphoma, kaya ito na ang tanging CAR T-cell therapy na may ganitong pinalawak na label.
• Nakaiskedyul ang Gilead na maglabas ng Q4 2025 earnings sa Pebrero 10, 2026, kung saan tinataya ng mga analyst ang $1.87 EPS at $7.68 bilyon na revenue matapos ang malakas na taon para sa HIV at oncology franchises nito.
• Ipinakita ng Phase 3 data na inilathala sa NEJM na ang kombinasyon ng Trodelvy at Keytruda ay malaki ang nabawas sa panganib ng paglala ng sakit ng 35% sa first-line metastatic triple-negative breast cancer.
• Inanunsyo ng Eli Lilly ang $2.4 bilyong acquisition ng Orna Therapeutics upang pumasok sa in vivo CAR-T therapy space, na nagpapakita ng patuloy na pag-usbong ng industriya sa advanced cell at gene therapies.
• Inilunsad ng FDA ang bagong "PreCheck" pilot program upang pabilisin ang konstruksyon at regulatory review ng mga domestic drug manufacturing facilities para palakasin ang pharmaceutical supply chain ng U.S.
See more
about 2D ago

GILD stock price forecast

According to technical indicators for GILD stock, the price is likely to fluctuate within the range of 147.25–176.79 USD over the next week. Market analysts predict that the price of GILD stock will likely fluctuate within the range of 141.42–180.97 USD over the next months.

Based on 1-year price forecasts from 85 analysts, the highest estimate is 387.07 USD, while the lowest estimate is 146.16 USD.

For more information, please see the GILD stock price forecast Stock Price Forecast page.

Latest GILD stock news

Nakamit ng AbbVie ang kasunduan sa administrasyon ni Trump tungkol sa presyo ng gamot kapalit ng pagbawas ng taripa

101 finance2026-01-13 09:26:17

Factbox-Nagmamadaling palakasin ng mga global drugmakers ang presensya sa US habang nagbabantang tumaas ang taripa

101 finance2026-01-13 13:23:24

Pananaw sa Kita ng Gilead Sciences: Mahahalagang Punto na Dapat Bantayan

101 finance2026-01-19 16:23:25

Itinaas ng BMO Capital ang target na presyo ng Gilead Sciences sa $150

格隆汇2026-01-27 07:45:54

Itinaas ng Truist ang target na presyo ng Gilead Sciences sa $145

格隆汇2026-01-28 08:22:01

Gilead: Pangkalahatang-ideya ng Kita para sa Ikaapat na Kwarto

101 finance2026-02-10 21:23:50

Iniulat ng Gilead Sciences (NASDAQ:GILD) ang benta para sa ikaapat na quarter ng 2025 na lumampas sa mga inaasahan

101 finance2026-02-10 21:30:07

Tiningnan ng Gilead Sciences ang pananaw para sa fiscal year 2026 sa kanilang pinakabagong ulat.

老虎证券2026-02-10 22:21:45

Ang pananaw ng Gilead para sa 2026 ay mas mababa kaysa sa inaasahan ng Wall Street, bumaba ang presyo ng stock

新浪财经2026-02-10 23:29:08

Paggalaw ng US stocks丨Gilead Sciences bumaba ng 1.8% sa night trading, ang gabay sa benta ng produkto at kita ngayong taon ay mas mababa kaysa inaasahan

格隆汇2026-02-11 02:15:01

Mga Mahahalagang Punto Bago Magbukas ang US Stock Market | Paparating ang Mahalagang Datos ng US January Non-Farm Payroll! Plano ni Trump na Maglabas ng Executive Order para Buhayin Muli ang Industriya ng Uling

格隆汇2026-02-11 12:39:30

Sa isang Bitget account lang, maaari kang mag-trade ng mga stock at cryptocurrencies nang sabay.

Join now!

FAQ

What is the stock price of Gilead Sciences, Inc.?

GILD ay kasalukuyang nakapresyo sa 149.96 USD — ang presyo nito ay nagbago ng -1.13% sa nakalipas na 24 na oras. Maaari mong subaybayan ang pagganap ng presyo ng stock ng Gilead Sciences, Inc. mas malapit sa chart ng presyo sa tuktok ng pahinang ito.

What is the stock ticker of Gilead Sciences, Inc.?

Depende sa exchange, maaaring mag-iba ang stock ticker. Halimbawa, sa NASDAQ, Gilead Sciences, Inc. ay tini-trade sa ilalim ng ticker GILD.

What is the stock forecast of GILD?

Nagtipon kami ng mga opinyon ng mga analyst tungkol sa Gilead Sciences, Inc.future price. Ayon sa kanilang mga pagtataya, GILD ay may pinakamataas na pagtatantya ng 1499.60 USD at isang minimum na pagtatantya ng 299.92 USD.

What is the market cap of Gilead Sciences, Inc.?

Gilead Sciences, Inc. ay may market capitalization ng 186.05B USD.

What is P/E ratio (TTM)?

The P/E ratio (TTM) stands for price-to-earnings ratio (trailing twelve months). It is a historical valuation metric calculated using a company's earnings per share (EPS) over the most recent twelve consecutive months, reflecting the company's past profitability.

The P/E ratio measures the relationship between a stock's price and a company's profitability, and is often used as a basis for judging whether a stock is "cheap" or "expensive."

P/E ratio = market price (P) ÷ earnings per share (EPS), or P/E ratio = total market capitalization ÷ net profit attributable to shareholders

The interpretation of the P/E ratio (TTM) should always be considered alongside other factors and is mainly used for valuation comparisons rather than as a standalone indicator.

  • A lower P/E ratio (TTM) means investors are paying less for each unit of earnings. This may indicate that the stock is undervalued, or that the market has limited expectations for the company's future growth, such as in mature or slow-growing industries.
  • A higher P/E ratio (TTM) means investors are paying more for each unit of earnings. This often reflects expectations of strong future earnings growth, which is common among growth or technology stocks, though it may also suggest the stock is overvalued.
  • Comparison with peers: Compare the company's P/E (TTM) with the average or median P/E of other companies in the same industry. A significantly higher P/E may require further analysis to determine whether the company's high valuation is justified by stronger growth prospects or competitive advantages.
  • Comparison with historical levels: Compare the company's current P/E (TTM) with its own historical average (such as over the past 5 or 10 years) to assess whether the current valuation is at a historical high or low.
  • Comparison with the broader market: Compare the company's P/E (TTM) with major market indices (such as the S&P 500) to see how the market is valuing the company overall.

P/E ratios can vary widely across industries, and there is no single "ideal" P/E level. A reasonable P/E range depends on the industry, the company's growth potential, and the broader macroeconomic environment. Investment decisions should not rely solely on the P/E ratio (TTM) but should be based on a comprehensive analysis that includes company quality, growth prospects, and financial health.

Can I trade stocks on Bitget?

You can trade stocks on Bitget, but mainly through stock tokens and stock perps, rather than by directly buying or selling traditional stocks.

This approach reflects Bitget's vision as a Universal Exchange (UEX), designed to connect traditional financial markets with cryptocurrency markets.

Bitget currently offers the following stock-related trading formats:

1. Stock tokens (spot)

Nature: Stock tokens are digital tokens pegged to the price of specific traditional stocks (such as TSLAUSDT and NVDAUSDT) and are traded on Bitget's spot market.

Features: When you trade stock tokens, you are buying and holding tokens rather than owning the underlying traditional stocks.

  • The price of these tokens generally follows the price movements of the stocks they are pegged to, such as Tesla or Nvidia.
  • The advantage is that you can participate in the price movements of traditional financial assets, such as U.S. stocks, using cryptocurrencies (for example, USDT), without the need for a traditional brokerage account.

2. Stock perps

Nature: Bitget also offers USDT-margined perpetual futures, commonly referred to as stock perps, based on major U.S. blue-chip stocks such as Tesla and Meta.

Characteristics: Stock perps are derivative products that allow you to take a bullish or bearish view on the future price of an underlying stock through margin trading. These products typically support leverage, such as up to 25x.

It does not involve owning the underlying stock. Instead, profits and losses are settled based on price movements of the futures.

Important note: When trading stock perps on Bitget, you are participating in derivative markets within the cryptocurrency ecosystem. This is fundamentally different from purchasing publicly traded shares through a traditional brokerage, as you do not own equity in the underlying company.

Futures trading and the use of leverage involve high risk. Please ensure you fully understand the risks before trading.

If you wish to directly hold equity in traditional stocks and enjoy shareholder rights (such as receiving dividends), you must trade through a regulated traditional securities brokerage or brokerage platform.

What are the advantages of Bitget's stock perps?

Bitget's stock perps—typically perpetual futures based on stock tokens prices—are an innovative offering that allows cryptocurrency platforms to provide exposure to traditional financial markets.

Compared to traditional stock or futures trading, they offer several unique advantages, primarily due to the platform's trading infrastructure.

Bitget's stock perps, typically USDT-denominated derivatives, offer the following key advantages:

1. Trading convenience and global accessibility

  • 24/7 trading: Traditional stock markets, such as U.S. equity markets, operate during fixed trading hours. In contrast, cryptocurrency derivatives markets are typically open 24/7. This means investors can trade anytime, capitalizing on breaking news or market fluctuations.
  • Lower entry barriers and faster onboarding: Compared with traditional brokerages, which often require extensive identity verification and lengthy account setup processes, Bitget generally offers faster account onboarding. Users can trade using cryptocurrencies such as USDT, without the need for complex fiat deposit and withdrawal procedures.
  • Global accessibility: Users can access derivatives trading linked to globally recognized stocks via the Bitget platform, subject to applicable regulations.

2. Capital efficiency and high leverage

  • High leverage options: Stock perps typically offer higher leverage than traditional stock trading (for example, up to 25x). This allows traders to control larger positions with smaller margin requirements, improving capital efficiency.
    Note: While high leverage can amplify gains, it also amplifies losses proportionally.
  • Two-way trading: Traders can easily take both long and short positions. This means traders can potentially profit from market volatility whether stock prices rise or fall, provided the market direction is correctly anticipated.

3. Trading and settlement using cryptocurrency

  • USDT margin: Stock perps on Bitget typically use USDT (or other stablecoins) as the margin and settlement currency. For users who already hold cryptocurrency, there is no need to convert assets into fiat currency, allowing them to trade directly with stablecoins.
  • Efficient fund transfers: Crypto-based transfers and settlements are typically faster than traditional fiat systems, enabling more efficient global fund allocation.

4. Integration

One-stop platform: Bitget allows users to trade spot cryptocurrencies, crypto derivatives, and stock perps on a single platform, making it easier to manage different asset types in one place.

Risk warning:

While Bitget's stock perps offer several advantages, it is important to understand the associated risks.

  • High leverage risk: Leveraged trading can result in rapid loss of your entire margin.
  • No equity ownership: When trading stock perps, you do not own the underlying shares. As a result, you are not entitled to dividends or voting rights.
  • Market liquidity risk: Tokenized stock perps may have lower liquidity than their counterparts in traditional stock markets, especially outside regular trading hours.

In summary, Bitget's stock perps offer advantages such as greater trading flexibility, lower entry barriers, and higher capital efficiency.

What are the trading fees for Bitget stock perps?

Trading fees for Bitget stock perps (USDT-margined perpetual futures) mainly include transaction fees and funding rates.

Transaction fees:

Bitget offers limited-time fee promotions for stock perps (especially tokenized stock perps) from time to time to attract traders.

Standard reference rates: Under Bitget's standard futures fee structure, the taker fee is typically around 0.06%, while the maker fee is around 0.02%.

Current promotions for stock perps (important): To promote its stock perps products, Bitget is offering discounted transaction fees during Q4 2025, with taker fees as low as 0.006% and maker fees as low as 0.002%. There is also a limited-time promotion offering zero-fee trading for spot stock tokens.

Recommendation: Since promotional activities are subject to change or end at any time, please visit Bitget's official " Fee overview " or " Announcement Center " page for the latest and most accurate rates at the time of trading.

Funding rate:

The funding rate is a key mechanism in perpetual futures (including stock perps) that helps keep the futures price closely aligned with the spot price of the underlying asset. It is not a fee charged by the platform, but a periodic payment exchanged between long and short traders.

Funding rates fluctuate dynamically and are mainly driven by market sentiment and imbalances between long and short positions. Stock perps generally experience lower volatility than cryptocurrencies, so funding rates are often relatively low during stable market conditions. However, during earnings seasons or major positive or negative news events, heavy concentration of long or short positions—such as in high-growth technology stocks like Tesla or Nvidia—can create significant imbalances, causing funding rates to spike in the short term.

Funding payments are typically settled every 8 hours. If you close your position before the funding settlement time, no funding payment will be charged or received.

Funding rates are not fixed. If you hold a position for an extended period, high positive funding rates (for long positions) or high negative funding rates (for short positions) will affect your overall holding costs or potential returns. For this reason, it is important to monitor the funding rate in real time on the trading interface.

NASDAQ/
GILD